Brief: Alligator Bioscience CMO Leaves
March 24 (Reuters) - Alligator Bioscience AB ATORX.ST: SAID ON FRIDAY SUMEET AMBARKHANE MD, CHIEF MEDICAL OFFICER, WILL BE LEAVING ALLIGATOR BY END OF MARCH 2025 TOM MOORE WILL ASSUME ROLE AS CHIEF MEDICAL OFFICER FROM BEGINNING OF APRIL Source text for Workspace: nMFN9LMSFC Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue